Cargando…

Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs

CRISPR-Cas9 nucleases are powerful genome engineering tools, but unwanted cleavage at off-target and previously edited sites remains a major concern. Numerous strategies to reduce unwanted cleavage have been devised, but all are imperfect. Here, we report that off-target sites can be shielded from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, John C., Popp, Nicholas A., Richardson, Christopher D., Stephany, Jason J., Mathieu, Julie, Wei, Cindy T., Corn, Jacob E., Maly, Dustin J., Fowler, Douglas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264211/
https://www.ncbi.nlm.nih.gov/pubmed/32483117
http://dx.doi.org/10.1038/s41467-020-16542-9
_version_ 1783540928025198592
author Rose, John C.
Popp, Nicholas A.
Richardson, Christopher D.
Stephany, Jason J.
Mathieu, Julie
Wei, Cindy T.
Corn, Jacob E.
Maly, Dustin J.
Fowler, Douglas M.
author_facet Rose, John C.
Popp, Nicholas A.
Richardson, Christopher D.
Stephany, Jason J.
Mathieu, Julie
Wei, Cindy T.
Corn, Jacob E.
Maly, Dustin J.
Fowler, Douglas M.
author_sort Rose, John C.
collection PubMed
description CRISPR-Cas9 nucleases are powerful genome engineering tools, but unwanted cleavage at off-target and previously edited sites remains a major concern. Numerous strategies to reduce unwanted cleavage have been devised, but all are imperfect. Here, we report that off-target sites can be shielded from the active Cas9•single guide RNA (sgRNA) complex through the co-administration of dead-RNAs (dRNAs), truncated guide RNAs that direct Cas9 binding but not cleavage. dRNAs can effectively suppress a wide-range of off-targets with minimal optimization while preserving on-target editing, and they can be multiplexed to suppress several off-targets simultaneously. dRNAs can be combined with high-specificity Cas9 variants, which often do not eliminate all unwanted editing. Moreover, dRNAs can prevent cleavage of homology-directed repair (HDR)-corrected sites, facilitating scarless editing by eliminating the need for blocking mutations. Thus, we enable precise genome editing by establishing a flexible approach for suppressing unwanted editing of both off-targets and HDR-corrected sites.
format Online
Article
Text
id pubmed-7264211
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72642112020-06-12 Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs Rose, John C. Popp, Nicholas A. Richardson, Christopher D. Stephany, Jason J. Mathieu, Julie Wei, Cindy T. Corn, Jacob E. Maly, Dustin J. Fowler, Douglas M. Nat Commun Article CRISPR-Cas9 nucleases are powerful genome engineering tools, but unwanted cleavage at off-target and previously edited sites remains a major concern. Numerous strategies to reduce unwanted cleavage have been devised, but all are imperfect. Here, we report that off-target sites can be shielded from the active Cas9•single guide RNA (sgRNA) complex through the co-administration of dead-RNAs (dRNAs), truncated guide RNAs that direct Cas9 binding but not cleavage. dRNAs can effectively suppress a wide-range of off-targets with minimal optimization while preserving on-target editing, and they can be multiplexed to suppress several off-targets simultaneously. dRNAs can be combined with high-specificity Cas9 variants, which often do not eliminate all unwanted editing. Moreover, dRNAs can prevent cleavage of homology-directed repair (HDR)-corrected sites, facilitating scarless editing by eliminating the need for blocking mutations. Thus, we enable precise genome editing by establishing a flexible approach for suppressing unwanted editing of both off-targets and HDR-corrected sites. Nature Publishing Group UK 2020-06-01 /pmc/articles/PMC7264211/ /pubmed/32483117 http://dx.doi.org/10.1038/s41467-020-16542-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Rose, John C.
Popp, Nicholas A.
Richardson, Christopher D.
Stephany, Jason J.
Mathieu, Julie
Wei, Cindy T.
Corn, Jacob E.
Maly, Dustin J.
Fowler, Douglas M.
Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs
title Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs
title_full Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs
title_fullStr Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs
title_full_unstemmed Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs
title_short Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs
title_sort suppression of unwanted crispr-cas9 editing by co-administration of catalytically inactivating truncated guide rnas
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264211/
https://www.ncbi.nlm.nih.gov/pubmed/32483117
http://dx.doi.org/10.1038/s41467-020-16542-9
work_keys_str_mv AT rosejohnc suppressionofunwantedcrisprcas9editingbycoadministrationofcatalyticallyinactivatingtruncatedguidernas
AT poppnicholasa suppressionofunwantedcrisprcas9editingbycoadministrationofcatalyticallyinactivatingtruncatedguidernas
AT richardsonchristopherd suppressionofunwantedcrisprcas9editingbycoadministrationofcatalyticallyinactivatingtruncatedguidernas
AT stephanyjasonj suppressionofunwantedcrisprcas9editingbycoadministrationofcatalyticallyinactivatingtruncatedguidernas
AT mathieujulie suppressionofunwantedcrisprcas9editingbycoadministrationofcatalyticallyinactivatingtruncatedguidernas
AT weicindyt suppressionofunwantedcrisprcas9editingbycoadministrationofcatalyticallyinactivatingtruncatedguidernas
AT cornjacobe suppressionofunwantedcrisprcas9editingbycoadministrationofcatalyticallyinactivatingtruncatedguidernas
AT malydustinj suppressionofunwantedcrisprcas9editingbycoadministrationofcatalyticallyinactivatingtruncatedguidernas
AT fowlerdouglasm suppressionofunwantedcrisprcas9editingbycoadministrationofcatalyticallyinactivatingtruncatedguidernas